The present disclosure relates generally to high frequency chest wall oscillation (HFCWO) therapy systems, and more particularly, to HFCWO therapy systems suitable for use in a hospital or healthcare facility.
Manual percussion techniques of chest physiotherapy have been used for a variety of diseases, such as cystic fibrosis, emphysema, asthma and chronic bronchitis, to remove excess mucus that collects in the lungs. To bypass dependency on a caregiver to provide this therapy, chest wall oscillation devices have been developed to deliver HFCWO therapy to a patient. U.S. Pat. No. 7,615,017 discloses an illustrative HFCWO therapy system, which is hereby incorporated by reference herein.
The present disclosure includes one or more of the features recited in the appended claims and/or the following features which, alone or in any combination, may comprise patentable subject matter.
According to an aspect of the disclosed embodiments, a high frequency chest wall oscillation apparatus may include a housing. An air pulse generator may be carried by the housing. Circuitry may be carried by the housing and may be configured to control the air pulse generator. A control panel may be carried by the housing and may be coupled to the circuitry. The control panel may permit a user to select first and second respiratory ailments to be treated by application of pressure pulses from the air pulse generator to a chest of a patient. A first range of selectable baseline pressures of the pressure pulses for the first respiratory ailment may be different than a second range of selectable baseline pressures of the pressure pulses for the second respiratory ailment.
In some embodiments, the control panel may include a display screen with selectable buttons adjacent to the display screen. The control panel may include a touchscreen display.
Optionally, the first respiratory ailment may be cystic fibrosis. The second respiratory ailment may be one of bronchiectasis or a neuromuscular ailment.
It may be desired that the first range of selectable baseline pressures may have a maximum baseline pressure greater than a maximum baseline pressure of the second range of selectable baseline pressures. The first range of selectable baseline pressures may have a minimum baseline pressure greater than a minimum baseline pressure of the second range of selectable baseline pressures. A mean baseline pressure of the first range of selectable baseline pressures may be more than half of a mean baseline pressure of the second range of selectable baseline pressures. The mean baseline pressure of the first range of selectable baseline pressures may be at least one kPA greater than the mean baseline pressure of the second range of selectable baseline pressures. The first range of selectable baseline pressures may be between 2 kPa and 4.5 kPa. The second range of selectable baseline pressures may be between 1 kPa and 3 kPa.
It may be contemplated that a first time limit for applying the pressure pulses for the first respiratory ailment may be different than a second time limit for applying the pressure pulses for the second respiratory ailment. A first frequency of the pressure pulses for the first respiratory ailment may be different than a second frequency of the pressure pulses for the second respiratory ailment. The first frequency may be greater than the second frequency. The second frequency may be greater than the first frequency.
According to another aspect of the disclosed embodiments, a high frequency chest wall oscillation apparatus may include a housing. An air pulse generator may be carried by the housing. Circuitry may be carried by the housing and may be configured to control the air pulse generator. A control panel may be carried by the housing and may be coupled to the circuitry. The control panel may permit a user to select first and second respiratory ailments to be treated by application of pressure pulses from the air pulse generator to a chest of a patient. A first frequency of the pressure pulses for the first respiratory ailment may be different than a second frequency of the pressure pulses for the second respiratory ailment.
In some embodiments, the first frequency may be greater than the second frequency. The second frequency may be greater than the first frequency.
Optionally, a maximum baseline pressure of a first range of selectable baseline pressures of the pressure pulses for the first respiratory ailment may be greater than a maximum baseline pressure of a second range of selectable baseline pressures of the pressure pulses for the second respiratory ailment. A minimum baseline pressure of a first range of selectable baseline pressures of the pressure pulses for the first respiratory ailment may be greater than a minimum baseline pressure of a second range of selectable baseline pressures of the pressure pulses for the second respiratory ailment. A mean baseline pressure of the first range of selectable baseline pressures may be more than half of a mean baseline pressure of the second range of selectable baseline pressures. The mean baseline pressure of the first range of selectable baseline pressures may be at least one kPA greater than the mean baseline pressure of the second range of selectable baseline pressures. The first range of selectable baseline pressures may be between 2 kPa and 4.5 kPa. The second range of selectable baseline pressures may be between 1 kPa and 3 kPa.
In some embodiments, the first respiratory ailment may be cystic fibrosis. The second respiratory ailment may be one of bronchiectasis or a neuromuscular ailment. It may be contemplated that a first time limit for applying the pressure pulses for the first respiratory ailment may be different than a second time limit for applying the pressure pulses for the second respiratory ailment. The first time limit may be greater than the second time limit. The second time limit may be greater than the first time limit.
It may be desired that the circuitry controls the air pulse generator by transmitting a current to the air pulse generator. The current may be adjustable to adjust an intensity of the pressure pulses from the air pulse generator.
According to yet another aspect of the disclosed embodiments, a high frequency chest wall oscillation apparatus may include a garment configured to be positioned over a chest of a patient. An air pulse generator may be pneumatically coupled to the garment. Circuitry may be carried by the garment and may be configured to control the air pulse generator. A control panel may be carried by the housing and may be coupled to the circuitry. The control panel may permit a user to select first and second respiratory ailments to be treated by application of pressure pulses from the air pulse generator to the chest of the patient. A first range of selectable baseline pressures of the pressure pulses for the first respiratory ailment may be different than a second range of selectable baseline pressures of the pressure pulses for the second respiratory ailment.
In some embodiments, the control panel may include a display screen with selectable buttons adjacent to the display screen. The control panel may include a touchscreen display.
It may be desired that the first respiratory ailment may be cystic fibrosis. The second respiratory ailment may be one of bronchiectasis or a neuromuscular ailment.
Optionally, the first range of selectable baseline pressures may have a maximum baseline pressure greater than a maximum baseline pressure of the second range of selectable baseline pressures. The first range of selectable baseline pressures may have a minimum baseline pressure greater than a minimum baseline pressure of the second range of selectable baseline pressures. A mean baseline pressure of the first range of selectable baseline pressures may be more than half of a mean baseline pressure of the second range of selectable baseline pressures. The mean baseline pressure of the first range of selectable baseline pressures may be at least one kPA greater than the mean baseline pressure of the second range of selectable baseline pressures. The first range of selectable baseline pressures may be between 2 kPa and 4.5 kPa. The second range of selectable baseline pressures may be between 1 kPa and 3 kPa.
It may be contemplated that a first time limit for applying the pressure pulses for the first respiratory ailment may be different than a second time limit for applying the pressure pulses for the second respiratory ailment. A first frequency of the pressure pulses for the first respiratory ailment may be different than a second frequency of the pressure pulses for the second respiratory ailment. The first frequency may be greater than the second frequency. The second frequency may be greater than the first frequency.
According to a further aspect of the disclosed embodiments, a high frequency chest wall oscillation apparatus may include a housing. An air pulse generator may be carried by the housing. Circuitry may be carried by the housing and may be configured to control the air pulse generator. A control panel may be carried by the housing and may be coupled to the circuitry. The control panel may permit a user to select first, second, and third respiratory ailments to be treated by application of pressure pulses from the air pulse generator to a chest of a patient. A first range of selectable baseline pressures of the pressure pulses for the first respiratory ailment may be different than a second range of selectable baseline pressures of the pressure pulses for the second respiratory ailment. A third range of selectable baseline pressures of the pressure pulses for the third respiratory ailment may be different than the first range of selectable baseline pressures of the pressure pulses. The second range of selectable baseline pressures of the pressure pulses may be the same as the third range of selectable baseline pressures of the pressure pulses.
In some embodiments, the control panel may include a display screen with selectable buttons adjacent to the display screen. The control panel may include a touchscreen display.
Optionally, the first respiratory ailment may be cystic fibrosis. The second respiratory ailment may be bronchiectasis. The third respiratory ailment may be a neuromuscular ailment.
It may be desired that the first range of selectable baseline pressures may have a maximum baseline pressure greater than a maximum baseline pressure of at least one of the second range of selectable baseline pressures and the third range of selectable baseline pressures. The first range of selectable baseline pressures may have a minimum baseline pressure greater than a minimum baseline pressure of at least one of the second range of selectable baseline pressures and the third range of selectable baseline pressures. A mean baseline pressure of the first range of selectable baseline pressures may be more than half of a mean baseline pressure of at least one of the second range of selectable baseline pressures and the third range of selectable baseline pressures. The mean baseline pressure of the first range of selectable baseline pressures may be at least one kPA greater than the mean baseline pressure of at least one of the second range of selectable baseline pressures and the third range of selectable baseline pressures. The first range of selectable baseline pressures may be between 2 kPa and 4.5 kPa. The second range of selectable baseline pressures may be between 1 kPa and 3 kPa. The third range of selectable baseline pressures may be between 1 kPa and 3 kPa. A first frequency of the pressure pulses for the first respiratory ailment may be different than at least one of a second frequency of the pressure pulses for the second respiratory ailment and a third frequency of the pressure pulses for the third respiratory ailment.
Additional features, which alone or in combination with any other feature(s), such as those listed above and/or those listed in the claims, can comprise patentable subject matter and will become apparent to those skilled in the art upon consideration of the following detailed description of various embodiments exemplifying the best mode of carrying out the embodiments as presently perceived.
The detailed description particularly refers to the accompanying figures in which:
In operation, HFCWO apparatus 16 provides air pulses and a baseline pressure to garment 12. The air pulses oscillate garment 12, while the baseline pressure keeps garment 12 inflated. Garment 12 applies an oscillating compressive force to chest C of patient P. Thus, system 10 produces HFCWO to clear mucous or induce deep sputum from the lungs of patient P.
HFCWO apparatus 16 produces a pressure having a steady state air pressure component (or “baseline pressure”) and an oscillating air pressure component. The pressure is a resulting composite waveform of the oscillating air pressure component and the steady state air pressure component. The oscillating air pressure component is substantially comprised of air pulses, while the steady state air pressure component is substantially comprised of baseline pressure.
The force generated on the chest C by garment 12 has an oscillatory force component and a steady state force component. The steady state force component corresponds to the steady state air pressure component, and the oscillating force component corresponds to the oscillating air pressure component. In a preferred embodiment, the steady state air pressure is greater than atmospheric pressure with the oscillatory air pressure riding on the steady state air pressure. With this embodiment, the resulting composite waveform provides an entire oscillation cycle of garment 12 that is effective at moving chest C of patient P, because there is no point at which pressure applied to chest C by garment 12 is below atmospheric pressure. Chest movement is induced by apparatus 16 via garment 12 due to garment 12 having an effective pressure (i.e. greater than atmospheric pressure) on chest C.
In operation, user interface 28 allows patient P to control operating parameters of HFCWO apparatus 16. Air openings 30 connect hoses 14 to generator 16. Switch port 32 allows connection plug 36 to connect to HFCWO apparatus 16. Patient P controls activation/deactivation of HFCWO apparatus 16 through control switch 34.
Referring now to
The air pulse generator 60 is carried by the housing 18 and includes a blower 62 configured to supply air to the garment 12. A motor 64 oscillates the air from the blower 62 as it is delivered to the garment 12. The motor 64 includes a rotor 66 that rotates to oscillate a pair of diaphragm plates 68 that are coupled to respective diaphragms or membranes 69 which are made of resilient material such as rubber. An arm 70 is coupled between each diaphragm plate 68 and the rotor 66. As the rotor 66 rotates the arms 70 reciprocate back and forth in the direction of arrows 72 to oscillate the diaphragm plates 68. The oscillating diaphragm plates 68 and diaphragms 69 act on the airflow from the blower 62 to pulsate the air supplied to the garment 12. As described in more detail below, the air pulses are controlled with the user inputs 58 to provide a desired treatment to the patient based on an operating mode of the HFCWO apparatus 16.
Although the illustrative air pulse generator 60 uses reciprocating diaphragms 69 to generate oscillatory air pulses, other types of air pulse generators are used in other embodiments. For example, reciprocating pistons create air pulses in some embodiments. See, for example,
User interface 28 is shown in more detail in
Display panel 110 is preferably an LCD panel display, although other displays, such as LED, could also be used. Display panel 110 shows the status of HFCWO apparatus 16 and options available for usage. In some embodiments, display panel 110 is a touch screen display and user inputs 58, such as buttons 114, 116, 118, 120, 122, 124, 126, and 128 are shown on the touchscreen display and are selectable by the user to control apparatus 16 as described herein with regard to the same buttons on keypad 112.
Keypad 112 is preferably an elastomeric or rubber eight button keypad that surrounds display panel 110. ON button 114 is located on the left side of display panel 110, and OFF button 116 is located on the right side of display panel 110. UL 118, UM 122 and UR 126 are located along the top of display panel 110, and LL 120, LM 124 and LR 128 are located along the bottom of display panel 110.
Patient P may modify operation of HFCWO apparatus 16. HFCWO apparatus 16 also provides feedback to patient P as to its status. The messages are displayed as text on display panel 110.
The function of UL 118, LL 120, UM 122, LM 124, UR 126 and LR 128 varies depending on the current mode of HFCWO apparatus 16. Each button is programmed to control various functions including the frequency of the oscillating air pressure component, or air pulses, the steady state air pressure component, or baseline pressure, and a timer, which deactivates HFCWO apparatus 16 automatically at the end of a therapy session and will be more fully described below.
In the illustrative embodiment, the pressure of the pressurized air supplied to the garment 12 is dictated by a mode selected. The mode is selected based on a condition of the patient. For example, in the illustrative embodiment, the system 100 is configured to treat patients having one of cystic fibrosis (CF), bronchiectasis (BE), or a neuromuscular ailment (NMD). Each of these conditions may be treated using a separate mode of the system 100. In some embodiments, more than one condition may be treated with the same mode. For example, bronchiectasis and a neuromuscular ailment may be treated by one mode, while cystic fibrosis is treated with another mode.
As shown in
Once a mode is selected, an intensity screen 150 is used to select an intensity of the mode, as shown in
A frequency screen 152 is used to select a frequency of the mode, as shown in
In some embodiments, each treatment mode has a preselected frequency. For example, the CF mode may have a preselected first frequency, the BE mode may a preselected second frequency, and the NMD mode may have a preselected third frequency. In some embodiments, at least two of the first frequency, the second frequency, and the third frequency are the same. At least one of the second frequency and third frequency may be greater than the first frequency. Alternatively, at least one of the second frequency and the third frequency may be less than the first frequency. Moreover, the third frequency may be greater or less than the second frequency.
A time limit screen 154 is used to select a time limit of the mode, as shown in
In some embodiments, each treatment mode has a preselected time limit. For example, the CF mode may have a preselected first time limit, the BE mode may a preselected second time limit, and the NMD mode may have a preselected third time limit. In some embodiments, at least two of the first time limit, the second time limit, and the third time limit are the same. At least one of the second time limit and third time limit may be greater than the first time limit. Alternatively, at least one of the second time limit and the third time limit may be less than the first time limit. Moreover, the third time limit may be greater or less than the second time limit.
Referring now to
The baseline pressure range for the CF treatment mode 202 is illustrated as being between 2.3 kPA and 4.1 kPa. Notably, a broader range may be contemplated. For example, the baseline pressure range for the CF treatment mode 202 may be between 2 kPa and 4.5 kPa. Illustratively, for a first intensity of the CF treatment mode 202, the baseline pressure is 2.3 kPa; for a second intensity, the baseline pressure is 2.5 kPa; for a third intensity, the baseline pressure is 2.7 kPa; for a fourth intensity, the baseline pressure is 2.9 kPa; for a fifth intensity, the baseline pressure is 3.1 kPa; for a sixth intensity, the baseline pressure is 3.3 kPa; for a seventh intensity, the baseline pressure is 3.5 kPa; for an eighth intensity, the baseline pressure is 3.7 kPa; for a ninth intensity, the baseline pressure is 3.9 kPa; and for a tenth intensity, the baseline pressure is 4.1 kPa.
The baseline pressure range for the BE/NMD treatment mode 204 is illustrated as being between 1.4 kPA and 2.75 kPa. Notably, a broader range may be contemplated. For example, the baseline pressure range for the BE/NMD treatment mode 204 may be between 1 kPa and 3 kPa. Illustratively, for a first intensity of the BE/NMD treatment mode 204, the baseline pressure is 1.4 kPa; for a second intensity, the baseline pressure is 1.55 kPa; for a third intensity, the baseline pressure is 1.7 kPa; for a fourth intensity, the baseline pressure is 1.85 kPa; for a fifth intensity, the baseline pressure is 2 kPa; for a sixth intensity, the baseline pressure is 2.15 kPa; for a seventh intensity, the baseline pressure is 2.3 kPa; for an eighth intensity, the baseline pressure is 2.45 kPa; for a ninth intensity, the baseline pressure is 2.6 kPa; and for a tenth intensity, the baseline pressure is 2.75 kPa.
In the illustrative embodiment, the CF treatment mode 202 has a minimum baseline pressure that is greater than the minimum baseline pressure of the BE/NMD treatment mode 204. The CF treatment mode 202 also has a maximum baseline pressure that is greater than a maximum baseline pressure of the BE/NMD treatment mode. A mean baseline pressure of the CF treatment mode 202 is greater than a mean baseline pressure of the BE/NMD treatment mode 204. Also, the mean baseline pressure of the CF treatment 202 mode is at least 1 kPa greater than the mean baseline pressure of the BE/NMD treatment mode 204.
Although this disclosure refers to multiple embodiments, it will be appreciated that aspects of each embodiment may be utilized with other embodiments described herein.
This application claims priority under 35 U.S.C. § 119(e) to U.S. Provisional Patent Application Ser. No. 62/889,205, filed Aug. 20, 2019, which is expressly incorporated by reference herein.
Number | Date | Country | |
---|---|---|---|
62889205 | Aug 2019 | US |